From a clinical perspective, how do you sequence therapies for patients with CTCL? What is the initial modality, and why, and when does ECP represent an evidence-based approach to treating CTCL? How many ECP treatments and at what frequency?
From a clinical perspective, how do you sequence therapies for patients with CTCL? What is the initial modality, and why, and when does ECP represent an evidence-based approach to treating CTCL? How many ECP treatments and at what frequency?
Presenter
Aaron B. and Marguerite Lerner Professor of Dermatology
Chair and Professor
Department of Dermatology
Yale School of Medicine